Compiled by Rupeestop LLP, SEBI RIA INA000022701. NAV as on 29 Sept 2026. Factsheet Jun 2026. About · Disclosures
Aditya Birla Sunlife Life Pharma and Healthcare Fund Direct IDCW Reinvestment
Aditya Birla Sun Life Mutual FundSectoral Pharma and HealthcareDirectIDCW
NAV
₹26.32
As on 29 Sept 2026
Vs category
| Period | This fund | Category | Rank |
|---|---|---|---|
| 1 year | +13.89% | — | — |
| 3 year | +15.88% | — | — |
| 5 year | +8.59% | — | — |
- Sharpe
- 0.98
- Std dev
- 15.29%
- Beta
- 0.90
All Sectoral Pharma and Healthcare funds · Aditya Birla Sun Life Mutual Fund
Returns
From NAVs through 29 Sept 2026
1Y
+13.89%
Total
3Y
+15.88%
p.a.
5Y
+8.59%
p.a.
SI
+8.21%
p.a.
Calendar years
-16.55%2022
+29.58%2023
+28.02%2024
-3.06%2025
+12.33%2026 YTD
Rolling 1-year · 51 overlapping windows
-20.05%avg +10.18%+54.06%
Fund facts
Fund details from the Jun 2026 factsheet
Fund size
₹950.31 Cr
Expense ratio
0.84%
Exit load
None
Lock-in
None
Launched10 Jul 2019
StructureOpen Ended
ISININF209KB1O33
Where the money is invested
Split by asset type.
By asset type
Equity96.83%
Cash3.17%
What the fund holds
40 holdings · portfolio as on 30 May 2026
- 12.42%Sun Pharmaceuticals Industries LtdHealthcare
- 7.31%Apollo Hospitals Enterprise LtdHealthcare
- 4.75%Torrent Pharmaceuticals LtdHealthcare
- 4.73%J.B. Chemicals & Pharmaceuticals LtdHealthcare
- 4.37%Aurobindo Pharma LtdHealthcare
- 3.99%Ajanta Pharma LtdHealthcare
- 3.89%Mankind Pharma LtdHealthcare
- 3.73%Lupin LtdHealthcare
- 3.65%Abbott India LtdHealthcare
- 3.31%Fortis Healthcare LtdHealthcare
Concentration
Top 5 weight
33.59%
Top 10 weight
52.16%
Avg turnover
43.33%
Risk and quality measures
How steady the returns have been.
Return quality
Sharpe
0.98
Better than category avg 0.98
Sortino
0.95
Return per unit of downside risk
Alpha
0.77
Return above the benchmark
Risk
Std deviation
15.29%
How much returns swing
Beta
0.9
Better than category avg 0.95
R-squared
92.9%
How closely it tracks the benchmark
Who manages this fund
1 fund manager
- DSDhaval Shah9.3 years in the industryRuns 9 schemes
Other Sectoral Pharma and Healthcare funds
ITI Pharma and Healthcare Fund - Direct Plan - GrowthdirectCompare
HDFC Pharma and Healthcare Fund Direct Plan GrowthdirectCompare
Tata India Pharma and Healthcare Fund Direct Plan GrowthdirectCompare
Whiteoak Capital Pharma and Healthcare Fund - Direct Plan - GrowthdirectCompare- Aditya Birla Sunlife Life Pharma and Healthcare Fund Direct GrowthdirectCompare
ICICI Prudential Pharma Healthcare and Diagnostics (p.h.d) Fund Direct Plan Growth-InsureddirectCompare- ITI Pharma and Healthcare Fund - Direct Plan - IDCW PayoutdirectCompare
- ITI Pharma and Healthcare Fund - Direct Plan - IDCW ReinvestmentdirectCompare
SIP illustration
Rate
+15.88%
Invested
₹6,00,000
Illustrated
₹14,71,357
₹5,000/mo × 10 years at this fund's 3Y CAGR. Illustration, not a forecast. SIP calculator
FAQ
What is Aditya Birla Sunlife Life Pharma and Healthcare Fund Direct IDCW Reinvestment NAV today?
- The latest NAV of Aditya Birla Sunlife Life Pharma and Healthcare Fund Direct IDCW Reinvestment is ₹26.32 as on 29 Sept 2026.
How has Aditya Birla Sunlife Life Pharma and Healthcare Fund Direct IDCW Reinvestment performed vs its category?
- 1-year return +13.89%. Past performance does not guarantee future returns.
What are the returns of Aditya Birla Sunlife Life Pharma and Healthcare Fund Direct IDCW Reinvestment?
- Trailing returns from published NAVs: 1 year +13.89%, 3 year +15.88% a year, 5 year +8.59% a year, since our first NAV +8.21% a year. Past performance does not guarantee future returns.
How would a SIP in Aditya Birla Sunlife Life Pharma and Healthcare Fund Direct IDCW Reinvestment have been illustrated?
- The SIP illustration on this page uses ₹5,000 a month for 10 years at this fund's 3-year annualised return of +15.88%. It is not a forecast.
What is the expense ratio and fund size of Aditya Birla Sunlife Life Pharma and Healthcare Fund Direct IDCW Reinvestment?
- For Aditya Birla Sunlife Life Pharma and Healthcare Fund Direct IDCW Reinvestment, the expense ratio is 0.84% and fund size (AUM) is ₹950.31 Cr.
What is the ISIN of Aditya Birla Sunlife Life Pharma and Healthcare Fund Direct IDCW Reinvestment?
- The ISIN for Aditya Birla Sunlife Life Pharma and Healthcare Fund Direct IDCW Reinvestment is INF209KB1O33.
Mutual fund investments are subject to market risks. Read all scheme related documents carefully before investing. Past performance does not guarantee future returns and is not an indicator of future results.
Figures on this page come from published NAVs and the scheme's monthly factsheet. They are for information only and are not investment advice or a recommendation to buy or sell any scheme.